{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:22:33Z","timestamp":1780503753705,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.amjmed.2019.01.039","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T05:13:16Z","timestamp":1551071596000},"page":"816-819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Misconceptions and Facts About Beta-Blockers"],"prefix":"10.1016","volume":"132","author":[{"given":"Edgar","family":"Argulian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripal","family":"Bangalore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz H.","family":"Messerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2019.01.039_bb0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1524-6175.2007.06492.x","article-title":"Patient and provider perceptions of hypertension treatment: do they agree?","volume":"9","author":"Kaboli","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0010","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2015.07.031","article-title":"Age differences in treatment and control of hypertension in US physician offices, 2003-2010: a serial cross-sectional study","volume":"129","author":"Gu","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.mayocp.2018.02.020","article-title":"What ever happened to cardioprotection with beta-blockers?","volume":"93","author":"Messerli","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0030","article-title":"Beta-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study","author":"Sorbets","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0035","doi-asserted-by":"crossref","first-page":"i4801","DOI":"10.1136\/bmj.i4801","article-title":"Beta blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study","volume":"354","author":"Puymirat","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0040","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0045","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCOUTCOMES.114.001073","article-title":"Beta-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0050","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"Beta-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0055","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1161\/CIRCULATIONAHA.107.695007","article-title":"Risk\/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension","volume":"117","author":"Messerli","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/HYPERTENSIONAHA.117.09259","article-title":"Risk of Cardiovascular events in patients with diabetes mellitus on beta-blockers","volume":"70","author":"Tsujimoto","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.mayocp.2017.11.019","article-title":"Risk of all-cause mortality in diabetic patients taking beta-blockers","volume":"93","author":"Tsujimoto","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0070","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199612053352301","article-title":"Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of Perioperative Ischemia Research Group","volume":"335","author":"Mangano","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000542-199801000-00005","article-title":"Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group","volume":"88","author":"Wallace","year":"1998","journal-title":"Anesthesiology."},{"key":"10.1016\/j.amjmed.2019.01.039_bb0080","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","author":"POISE Study Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0085","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.jacc.2014.07.939","volume":"64","author":"Wijeysundera","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0090","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(08)61560-3","article-title":"Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis","volume":"372","author":"Bangalore","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.005027","article-title":"Preoperative beta-Blockers for isolated coronary artery bypass graft","volume":"11","author":"da Graca","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamainternmed.2014.2356","article-title":"Preoperative beta-blocker use in coronary artery bypass grafting surgery: national database analysis","volume":"174","author":"Brinkman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0105","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2017.08.025","article-title":"Short-term effects of preoperative beta-blocker use for isolated coronary artery bypass grafting: A systematic review and meta-analysis","volume":"155","author":"Wang","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0110","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.279.23.1903","article-title":"Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review","volume":"279","author":"Messerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacc.2016.03.610","article-title":"When an increase in central systolic pressure overrides the benefits of heart rate lowering","volume":"68","author":"Messerli","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.amjmed.2014.11.015","article-title":"Misconceptions and facts about treating hypertension","volume":"128","author":"Argulian","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0125","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00129784-200808010-00005","article-title":"Efficacy and tolerability of nebivolol compared with other antihypertensive drugs: a meta-analysis","volume":"8","author":"Van Bortel","year":"2008","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0135","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1093\/eurheartj\/ehy701","article-title":"Alter ego(s) in coronary artery disease: insights from a recently departed patient","volume":"39","author":"Messerli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0140","article-title":"Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis","volume":"353","author":"Kotecha","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.288.3.351","article-title":"Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction","volume":"288","author":"Ko","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2019.01.039_bb0150","article-title":"Beta-blockers for hypertension","volume":"1","author":"Wiysonge","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319301524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319301524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:16:55Z","timestamp":1757582215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319301524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0002934319301524"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.01.039","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misconceptions and Facts About Beta-Blockers","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}